McGlone Suttner Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
McGlone Suttner Wealth Management's ABBV Position: Q2 2026 in Review
McGlone Suttner Wealth Management increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $37.2K and bringing the position to 12,160 shares worth $3.06M. The position accounts for 0.36% of the portfolio, ranked #31.
McGlone Suttner Wealth Management first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 1,743 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- McGlone Suttner Wealth Management held 12,160 shares of AbbVie worth $3.06M as of Q2 2026.
- McGlone Suttner Wealth Management bought 173 AbbVie shares in Q2 2026, an estimated $37.2K.
- AbbVie made up 0.36% of McGlone Suttner Wealth Management's portfolio in Q2 2026, its #31 holding.
- McGlone Suttner Wealth Management first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
- 1,743 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on McGlone Suttner Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.